A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D
Jung-Yun Lee
◽
Jae Weon Kim
◽
Myong Cheol Lim
◽
Sunghoon Kim
◽
Hee Seung Kim
◽
...
Young Shin Chung
◽
Sang-Yoon Park
◽
Jung-Yun Lee
◽
Jeong-Yeol Park
◽
Jeong-Won Lee
◽
...
1995 ◽
Vol 18
(2)
◽
pp. 156-157
◽
Alberto Manetta
◽
John A. Blessing
◽
Katherine Y. Look
1993 ◽
Vol 49
(1)
◽
pp. 48-50
◽
Gregory P. Sutton
◽
John A. Blessing
◽
Philip J. DiSaia
◽
William P. McGuire
2006 ◽
Vol 103
(2)
◽
pp. 523-526
◽
Paula M. Fracasso
◽
John A. Blessing
◽
Kelly L. Molpus
◽
Lisa M. Adler
◽
Joel I. Sorosky
◽
...
WilliamP. McGuire
◽
JohnA. Blessing
◽
MichaelL. Berman
1998 ◽
Vol 68
(1)
◽
pp. 45-46
◽
Alberto Manetta
◽
John A. Blessing
◽
Jean A. Hurteau
2014 ◽
Vol 134
(2)
◽
pp. 438-439
◽
R.J. Osborne
◽
V.L. Filiaci
◽
R.S. Mannel
◽
S.A. Davidson
◽
J.S. Hoffman
◽
...
2000 ◽
Vol 77
(1)
◽
pp. 112-115
◽
Maurie Markman
◽
John A. Blessing
◽
Ronald D. Alvarez
◽
Parviz Hanjani
◽
Steven Waggoner
◽
...
2001 ◽
Vol 81
(2)
◽
pp. 213-215
◽
Laila I. Muderspach
◽
John A. Blessing
◽
Charles Levenback
◽
James L. Moore
2012 ◽
Vol 125
(2)
◽
pp. 421-426
◽
Jennifer M. Rubatt
◽
Kathleen M. Darcy
◽
Chunqiao Tian
◽
Franco Muggia
◽
Rajiv Dhir
◽
...
Close
Export Citation Format
Close
Share Document
Close